Cargando…
Evidence for β(1)-adrenergic receptor involvement in amygdalar corticotropin-releasing factor gene expression: implications for cocaine withdrawal
We previously showed that betaxolol, a selective β(1)-adrenergic receptor antagonist, administered during early phases of cocaine abstinence, ameliorated withdrawal-induced anxiety and blocked increases in amygdalar β(1)-adrenergic receptor expression in rats. Here, we report the efficacy of betaxol...
Autores principales: | Rudoy, Carla A., Reyes, Arith-Ruth S., Van Bockstaele, Elisabeth J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660858/ https://www.ncbi.nlm.nih.gov/pubmed/18596687 http://dx.doi.org/10.1038/npp.2008.102 |
Ejemplares similares
-
Amygdalar Corticotropin-Releasing Factor Signaling Is Required for Later-Life Behavioral Dysfunction Following Neonatal Pain
por: Davis, Seth M., et al.
Publicado: (2021) -
Adolescent Binge Drinking Leads to Changes in Alcohol Drinking, Anxiety, and Amygdalar Corticotropin Releasing Factor Cells in Adulthood in Male Rats
por: Gilpin, Nicholas W., et al.
Publicado: (2012) -
Increased vulnerability of the brain norepinephrine system of females to corticotropin-releasing factor overexpression
por: Bangasser, Debra A., et al.
Publicado: (2012) -
Sex Differences in Corticotropin-Releasing Factor Receptor Signaling and Trafficking: Potential Role in Female Vulnerability to Stress-Related Psychopathology
por: Bangasser, Debra A., et al.
Publicado: (2010) -
Involvement of β-adrenergic receptor in synaptic vesicle swelling and implication in neurotransmitter release
por: Chen, Zhi Hui, et al.
Publicado: (2011)